Header Logo

Connection

Neil Martinson to Infectious Disease Transmission, Vertical

This is a "connection" page, showing publications Neil Martinson has written about Infectious Disease Transmission, Vertical.
  1. Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial. PLoS Med. 2009 Oct; 6(10):e1000172.
    View in: PubMed
    Score: 0,256
  2. Intensified case finding for tuberculosis in prevention of mother-to-child transmission programs: a simple and potentially vital addition for maternal and child health. J Acquir Immune Defic Syndr. 2009 Feb 01; 50(2):196-9.
    View in: PubMed
    Score: 0,243
  3. Transmission rates in consecutive pregnancies exposed to single-dose nevirapine in Soweto, South Africa and Abidjan, Côte d'Ivoire. J Acquir Immune Defic Syndr. 2007 Jun 01; 45(2):206-9.
    View in: PubMed
    Score: 0,217
  4. Combining PMTCT with active case finding for tuberculosis. J Acquir Immune Defic Syndr. 2006 Jul; 42(3):379-81.
    View in: PubMed
    Score: 0,203
  5. Maternal Motivation to Take Preventive Therapy in Antepartum and Postpartum Among HIV-Positive Pregnant Women in South Africa: A Choice Experiment. AIDS Behav. 2019 Jul; 23(7):1689-1697.
    View in: PubMed
    Score: 0,125
  6. Poor Obstetric and Infant Outcomes in Human Immunodeficiency Virus-Infected Pregnant Women With Tuberculosis in South Africa: The Tshepiso Study. Clin Infect Dis. 2018 03 05; 66(6):921-929.
    View in: PubMed
    Score: 0,114
  7. Prevention of TB using rifampicin plus isoniazid reduces nevirapine concentrations in HIV-exposed infants. J Antimicrob Chemother. 2017 07 01; 72(7):2028-2034.
    View in: PubMed
    Score: 0,109
  8. Costs along the service cascades for HIV testing and counselling and prevention of mother-to-child transmission. AIDS. 2016 10 23; 30(16):2495-2504.
    View in: PubMed
    Score: 0,104
  9. Identification of nevirapine-resistant HIV-1 in the latent reservoir after single-dose nevirapine to prevent mother-to-child transmission of HIV-1. J Infect Dis. 2009 May 01; 199(9):1301-9.
    View in: PubMed
    Score: 0,062
  10. Development of phenotypic HIV-1 drug resistance after exposure to single-dose nevirapine. J Acquir Immune Defic Syndr. 2008 Dec 15; 49(5):538-43.
    View in: PubMed
    Score: 0,060
  11. Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine. J Acquir Immune Defic Syndr. 2007 Feb 01; 44(2):148-53.
    View in: PubMed
    Score: 0,053
  12. Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission. Proc Natl Acad Sci U S A. 2006 May 02; 103(18):7094-9.
    View in: PubMed
    Score: 0,050
  13. Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated. J Infect Dis. 2005 Jul 01; 192(1):16-23.
    View in: PubMed
    Score: 0,047
  14. Maternal hepatitis B and infant infection among pregnant women living with HIV in South Africa. J Int AIDS Soc. 2014; 17:18871.
    View in: PubMed
    Score: 0,022
  15. Short-course Combivir after single-dose nevirapine reduces but does not eliminate the emergence of nevirapine resistance in women. Antivir Ther. 2012; 17(2):327-36.
    View in: PubMed
    Score: 0,018
  16. Low frequency of the V106M mutation among HIV-1 subtype C-infected pregnant women exposed to nevirapine. AIDS. 2003 Jul 25; 17(11):1698-700.
    View in: PubMed
    Score: 0,010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.